Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

June 4, 2025

Study Completion Date

June 4, 2025

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG

Sotagliflozin

Daily administration of sotagliflozin (2x200 mg, PO, OD) for 6 months.

DRUG

Placebo

Matching placebo for 6 months.

Trial Locations (1)

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Juan Badimon

OTHER